Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 459.37 billion as of January 8, 2025. Its market cap has increased by 106.12% in one year.

Market Cap

459.37B

Enterprise Value

458.98B

Revenue

130.80B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,641.55

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 459.37B, an increase of 39,869.79%. That is a compound annual growth rate of 28.89%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2025	459.37B	1.17%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	16.08T
Tata Consultancy Services	14.86T
HDFC Bank	12.96T
Bharti Airtel	9,566.14B
ICICI Bank	9,030.31B
Infosys	8,007.17B
State Bank of India	6,950.05B
Hindustan Unilever	5,637.96B

Market Cap Rankings